Belzempic EZUSE – Semaglutide – at a Glance
Semaglutide is a synthetic GLP-1 receptor agonist peptide extensively studied for its effects on glucose metabolism and energy homeostasis in laboratory models. The Belzempic EZUSE formulation provides researchers with a precisely dosed 2mg prefilled pen system manufactured by Beligas, offering convenient dosing accuracy for in-vitro investigations. This metabolic modulator demonstrates high binding affinity to GLP-1 receptors and exhibits prolonged half-life characteristics in preclinical studies, making it an important research tool for examining incretin hormone pathways. Scientists at Stroid UK Shop utilise semaglutide to investigate cellular signalling mechanisms related to glucose-dependent insulin secretion and gastric emptying modulation.
Laboratory Applications
Research applications for semaglutide span multiple areas of metabolic investigation, particularly focusing on pancreatic beta-cell function and incretin system modulation. Laboratory studies examine its mechanism of action through cAMP-dependent pathways and its effects on glucagon suppression in controlled experimental conditions. The compound’s structure, based on human GLP-1 with strategic amino acid modifications, provides researchers with a stable platform for investigating receptor pharmacology and downstream signalling cascades. Studies frequently analyse semaglutide’s interaction with metabolic regulatory compounds to understand comprehensive pathway interactions. Researchers also investigate its potential neuroprotective properties and effects on appetite regulation centres in neural tissue models.
Technical Specifications
| Parameter | Value |
|---|---|
| Chemical Name | Semaglutide |
| Molecular Formula | C187H291N45O59 |
| Molecular Weight | 4113.58 g/mol |
| CAS Number | 910463-68-2 |
| Purity | Verify with supplier |
| Form | Prefilled pen, 2mg |
| Storage | 2-8°C, protect from light |
The prefilled pen format ensures consistent research dosing and maintains compound stability throughout the study period. Research facilities benefit from the controlled delivery system which eliminates preparation variables common in reconstituted peptide research. Integration with selective androgen receptor modulators and peptide research compounds allows comprehensive investigation of metabolic pathway interactions.
Research Compliance
This semaglutide research compound is supplied strictly for in-vitro laboratory research and analytical purposes only. Not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure proper institutional oversight and safety protocols when handling this material.
